Cargando…
Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
BACKGROUND: Robust imaging biomarkers are needed for risk stratification in stage I lung adenocarcinoma patients in order to select optimal treatment regimen. We aimed to construct and validate a radiomics nomogram for predicting the disease-free survival (DFS) of patients with resected stage I lung...
Autores principales: | Xie, Dong, Wang, Ting-Ting, Huang, Shu-Jung, Deng, Jia-Jun, Ren, Yi-Jiu, Yang, Yang, Wu, Jun-Qi, Zhang, Lei, Fei, Ke, Sun, Xi-Wen, She, Yun-Lang, Chen, Chang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7481634/ https://www.ncbi.nlm.nih.gov/pubmed/32953490 http://dx.doi.org/10.21037/tlcr-19-577 |
Ejemplares similares
-
A potential biomarker based on clinical-radiomics nomogram for predicting survival and adjuvant chemotherapy benefit in resected node-negative, early-stage lung adenocarcinoma
por: Ma, Xiaoling, et al.
Publicado: (2022) -
Development and Validation of a Nomogram to Predict the Benefit of Adjuvant Radiotherapy for Patients with Resected Gastric Cancer
por: Yuan, Shu-Qiang, et al.
Publicado: (2017) -
Development and Validation of a Prognostic Nomogram Based on the Systemic Immune-Inflammation Index for Resectable Gallbladder Cancer to Predict Survival and Chemotherapy Benefit
por: Li, Lin, et al.
Publicado: (2021) -
Survival benefit and impact of adjuvant chemotherapy following systemic neoadjuvant chemotherapy in patients with resected pancreas ductal adenocarcinoma: a retrospective cohort study
por: Pu, Ning, et al.
Publicado: (2023) -
Identification of Pancreaticoduodenectomy Resection for Pancreatic Head Adenocarcinoma: A Preliminary Study of Radiomics
por: Hui, Bei, et al.
Publicado: (2020)